JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on January 25, 2007; DOI: 10.1124/jpet.106.116954


0022-3565/07/3211-98-106$20.00
JPET 321:98-106, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.116954v1
321/1/98    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, C.-W.
Right arrow Articles by Wu, S.-N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, C.-W.
Right arrow Articles by Wu, S.-N.

NEUROPHARMACOLOGY

Activation by Zonisamide, a Newer Antiepileptic Drug, of Large-Conductance Calcium-Activated Potassium Channel in Differentiated Hippocampal Neuron-Derived H19-7 Cells

Chin-Wei Huang, Chao-Ching Huang, and Sheng-Nan Wu

Department of Neurology (C.-W.H.) and Institute of Clinical Medicine (C.-W.H., C.-C.H.), Department of Pediatrics (C.-C.H.), and Department of Physiology and Institute of Basic Medical Sciences (S.-N.W.), National Cheng Kung University Medical College, Tainan, Taiwan

Zonisamide (ZNS; 3-sulfamoylmethyl-1,2-benzisoxazole), as one of the newer antiepileptic drugs, has been demonstrated its broad-spectrum clinical efficacy on various neuropsychiatric disorders. However, little is known regarding the mechanism of ZNS actions on ion currents in neurons. We thus investigated its effect on ion currents in differentiated hippocampal 19-7 cells. In whole-cell configuration of patch-clamp technology, the ZNS (30 µM) reversibly increased the amplitude of K+ outward currents, and paxilline (1 µM) was effective in suppressing the ZNS-induced increase of K+ outward currents. In inside-out configuration, ZNS (30 µM) applied to the intracellular face of the membrane did not alter single-channel conductance; however, it did enhance the activity of large-conductance Ca2+-activated K+ (BKCa) channels primarily by decreasing mean closed time. In addition, the EC50 value for ZNS-stimulated BKCa channels was 34 µM. This drug caused a left shift in the activation curve of BKCa channels, with no change in the gating charge of these channels. Moreover, ZNS at a concentration greater than 100 µM also reduced the amplitude of A-type K+ current in these cells. A simulation modeling based on hippocampal CA3 pyramidal neurons (Pinsky-Rinzel model) was also analyzed to investigate the inhibitory effect of ZNS on the firing of simulated action potentials. Taken together, this study suggests that, in hippocampal neurons during the exposure to ZNS, the ZNS-mediated effects on BKCa channels and A-type K+ current could be potential mechanisms through which it affects neuronal excitability.


Received November 15, 2006; accepted January 23, 2007.

Address correspondence to: Dr. Sheng-Nan Wu, Department of Physiology, National Cheng Kung University Medical College, 1 University Road, Tainan 70101, Taiwan. E-mail: snwu{at}mail.ncku.edu.tw







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.